Driver mutations in IDH1 and IDH2 have been likewise identified in acute myeloid leukemia (AML), chondrosarcoma, myelodysplastic syndromes, and cholangiocarcinoma (3–6). The gene discussed is IDH1; the disease is cholangiocarcinoma.